OnKure Therapeutics Rings the Closing Bell

About This Event

OnKure Therapeutics (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Nicholas Saccomano, President and Chief Executive Officer rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore